ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34 | 0.0% | 1,586 | 0.0% | 0.00% | – |
| Q2 2023 | $34 | -46.9% | 1,586 | 0.0% | 0.00% | – |
| Q1 2023 | $64 | -22.0% | 1,586 | 0.0% | 0.00% | – |
| Q4 2022 | $82 | -99.9% | 1,586 | 0.0% | 0.00% | – |
| Q3 2022 | $82,000 | +9.3% | 1,586 | 0.0% | 0.00% | – |
| Q2 2022 | $75,000 | -33.6% | 1,586 | 0.0% | 0.00% | – |
| Q1 2022 | $113,000 | -85.4% | 1,586 | -87.7% | 0.00% | -100.0% |
| Q3 2019 | $772,000 | -58.3% | 12,843 | -41.5% | 0.01% | -57.1% |
| Q2 2019 | $1,852,000 | -16.8% | 21,947 | -5.8% | 0.01% | -22.2% |
| Q1 2019 | $2,225,000 | -24.2% | 23,297 | -43.8% | 0.02% | -45.5% |
| Q4 2018 | $2,934,000 | +61.7% | 41,421 | +95.2% | 0.03% | +135.7% |
| Q3 2018 | $1,814,000 | – | 21,223 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |